HRT Financial’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-18,163
Closed -$864K 2832
2023
Q3
$864K Buy
+18,163
New +$991K 0.01% 1082
2023
Q1
Sell
-21,887
Closed -$1.54M 2951
2022
Q4
$1.54M Sell
21,887
-23,999
-52% -$1.69M 0.02% 718
2022
Q3
$2.78M Buy
45,886
+32,091
+233% +$2.15M 0.03% 492
2022
Q2
$871K Buy
+13,795
New +$899K 0.01% 1048
2022
Q1
Sell
-4,874
Closed -$349K 3605
2021
Q4
$349K Sell
4,874
-24,328
-83% -$1.85M ﹤0.01% 2162
2021
Q3
$2.08M Buy
29,202
+21,816
+295% +$1.72M 0.01% 706
2021
Q2
$600K Buy
+7,386
New +$594K 0.01% 1606
2021
Q1
Sell
-4,081
Closed -$309K 3000
2020
Q4
$309K Sell
4,081
-10,261
-72% -$668K 0.01% 1273
2020
Q3
$709K Buy
+14,342
New +$809K 0.02% 723
2019
Q4
Sell
-6,370
Closed -$540K 1479
2019
Q3
$540K Buy
+6,370
New +$567K 0.03% 641

Other funds holding NGVT

HRT Financial's NGVT Position: Q4 2023 in Review

HRT Financial sold out of Ingevity (NGVT) in Q4 2023, closing a stake of 18,163 shares — an estimated $864K sold.

HRT Financial first reported a position in NGVT in Q3 2019 and held it in 10 quarters. The position peaked at $2.78M in Q3 2022. 252 funds tracked by Wall St. Rank hold NGVT as of Q4 2023.

  • HRT Financial reported no remaining Ingevity position as of Q4 2023 after selling out during the quarter.
  • HRT Financial sold 18,163 Ingevity shares in Q4 2023, an estimated $864K.
  • HRT Financial first reported a position in Ingevity in Q3 2019 and held it in 10 quarters.
  • HRT Financial's Ingevity position peaked at $2.78M in Q3 2022.
  • 252 funds tracked by Wall St. Rank held Ingevity as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.